Healthcare provider profile · identity verified

Thomas Florian Kurland, DO

Allopathic & Osteopathic Physicians|Internal Medicine · YORK, PA · NPI 1679549901

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Thomas Florian Kurland, DO received $117.51 in general payments during 2025 across 4 reported records.

Medtronic, Inc. accounted for 51.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Creon by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Synthroid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$117.51

4 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$60.55	51.5%	1	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$42.06	35.8%	2	2025
Astellas Pharma US Inc	Unresolved — no canonical attribution shown	$14.90	12.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$117.51	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
INCEPTIV Normalized: inceptiv	Device	Medtronic, Inc.	$60.55	1	2025
Source payment records 2025-06-25 · Medtronic, Inc. · $60.55 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$42.06	2	2025
Source payment records 2025-03-13 · ABBVIE INC. · $14.36 · Open Payments source 2025-10-09 · ABBVIE INC. · $27.70 · Open Payments source
Veozah Normalized: veozah	Drug	Astellas Pharma US Inc	$14.90	1	2025
Source payment records 2025-07-29 · Astellas Pharma US Inc · $14.90 · Open Payments source
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$14.36	1	2025
Source payment records 2025-03-13 · ABBVIE INC. · $14.36 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	18	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	58	16

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	962	259
Amlodipine Besylate	Amlodipine Besylate	645	186
Pantoprazole Sodium	Pantoprazole Sodium	402	112
Metoprolol Succinate	Metoprolol Succinate	392	109
Levothyroxine Sodium	Levothyroxine Sodium	370	95
Lisinopril	Lisinopril	363	104
Rosuvastatin Calcium	Rosuvastatin Calcium	310	94
Metformin Hcl	Metformin Hcl	299	90
Eliquis	Apixaban	281	63
Tamsulosin Hcl	Tamsulosin Hcl	278	76
Losartan Potassium	Losartan Potassium	268	78
Furosemide	Furosemide	248	81
Omeprazole	Omeprazole	237	68
Gabapentin	Gabapentin	224	63
Hydrochlorothiazide	Hydrochlorothiazide	217	63
Simvastatin	Simvastatin	209	54
Pravastatin Sodium	Pravastatin Sodium	181	47
Sertraline Hcl	Sertraline Hcl	161	47
Clopidogrel	Clopidogrel Bisulfate	155	46
Alprazolam	Alprazolam	145	31
Lorazepam	Lorazepam	145	38
Glimepiride	Glimepiride	138	40
Metoprolol Tartrate	Metoprolol Tartrate	136	41
Allopurinol	Allopurinol	132	33
Escitalopram Oxalate	Escitalopram Oxalate	132	42
Meloxicam	Meloxicam	130	47
Prednisone	Prednisone	128	77
Albuterol Sulfate Hfa	Albuterol Sulfate	125	45
Atenolol	Atenolol	121	33
Carvedilol	Carvedilol	117	32
Diclofenac Sodium	Diclofenac Sodium	113	34
Tramadol Hcl	Tramadol Hcl	110	34
Fluoxetine Hcl	Fluoxetine Hcl	102	32
Jardiance	Empagliflozin	100	24
Potassium Chloride	Potassium Chloride	94	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	11
Duloxetine Hcl	Duloxetine Hcl	90	16
Finasteride	Finasteride	90	26
Ozempic	Semaglutide	86	16
Trazodone Hcl	Trazodone Hcl	85	23
Nifedipine Er	Nifedipine	80	20
Olmesartan Medoxomil	Olmesartan Medoxomil	78	21
Oxycodone Hcl	Oxycodone Hcl	75	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	21
Baclofen	Baclofen	72	29
Azithromycin	Azithromycin	70	53
Bupropion Xl	Bupropion Hcl	70	23
Pioglitazone Hcl	Pioglitazone Hcl	68	19
Donepezil Hcl	Donepezil Hcl	67	23
Valsartan	Valsartan	60	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	16
Synthroid	Levothyroxine Sodium	58	16
Zolpidem Tartrate	Zolpidem Tartrate	58	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	13
Citalopram Hbr	Citalopram Hydrobromide	55	15
Ezetimibe	Ezetimibe	55	18
Hydralazine Hcl	Hydralazine Hcl	54	16
Alendronate Sodium	Alendronate Sodium	52	16
Paroxetine Hcl	Paroxetine Hcl	52	14
Celecoxib	Celecoxib	51	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	12
Breo Ellipta	Fluticasone/Vilanterol	50	suppressed
Metformin Hcl Er	Metformin Hcl	50	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	12
Spironolactone	Spironolactone	47	14
Amoxicillin	Amoxicillin	45	27
Cephalexin	Cephalexin	45	42
Fluticasone Propionate	Fluticasone Propionate	45	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	11
Fenofibrate	Fenofibrate Nanocrystallized	42	15
Solifenacin Succinate	Solifenacin Succinate	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	12
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	22
Montelukast Sodium	Montelukast Sodium	38	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Warfarin Sodium	Warfarin Sodium	37	11
Hydroxyzine Hcl	Hydroxyzine Hcl	36	13
Clonazepam	Clonazepam	35	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	13
Methylphenidate Hcl	Methylphenidate Hcl	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Telmisartan	Telmisartan	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Famotidine	Famotidine	29	11
Propranolol Hcl	Propranolol Hcl	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	14
Pregabalin	Pregabalin	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Methylprednisolone	Methylprednisolone	26	22
Mirtazapine	Mirtazapine	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	16
Fenofibrate	Fenofibrate	23	suppressed
Risperidone	Risperidone	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	13
Diazepam	Diazepam	19	suppressed
Glipizide	Glipizide	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Carisoprodol	Carisoprodol	18	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Primidone	Primidone	18	suppressed
Topiramate	Topiramate	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	16
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Invokana	Canagliflozin	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Terazosin Hcl	Terazosin Hcl	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Testosterone	Testosterone	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Linzess	Linaclotide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Nucynta	Tapentadol Hcl	13	suppressed
Nyamyc	Nystatin	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Ramipril	Ramipril	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$117.51 · 4 records	Medtronic, Inc.	INCEPTIV, QULIPTA, UBRELVY, Veozah	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error